Climb Bio Inc.

CLYM | NASDAQ

Price Alert Chart Builder DCF Calculator

$10.24

-$0.09 (-0.87%)

At close: Oct 30, 2026, 3:59 PM ET

$10.25

+$0.01 (+0.10%)

Pre-market: Nov 2, 2026, 4:36 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 31, 2025	FY 2024 Dec 31, 2024	FY 2023 Dec 31, 2023	FY 2022 Dec 31, 2022	FY 2021 Dec 31, 2021	FY 2020 Dec 31, 2020
Net Income	-59.85M	-73.9M	-35.12M	-45.24M	-47.48M	-20.67M
Depreciation & Amortization	97K	n/a	n/a	n/a	n/a	n/a
Stock-Based Compensation	8.05M	5.56M	12.81M	6.99M	3.74M	707K
Other Working Capital	-2.17M	2.84M	4.45M	863K	-4.49M	-2.91M
Other Non-Cash Items	-2.06M	51.08M	-2.05M	674K	11.84M	8.8M
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	-601K	1.7M	3.76M	210K	-4.17M	-2.94M
Operating Cash Flow	-54.36M	-15.56M	-20.6M	-37.37M	-36.07M	-14.1M
Capital Expenditures	-186K	n/a	n/a	n/a	n/a	n/a
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	-108.08M	-132.2M	-58.45M	-87.96M	-114.97M	n/a
Sales Maturities Of Investments	111.1M	20.75M	127.43M	122.4M	n/a	n/a
Other Investing Acitivies	n/a	-9.65M	n/a	n/a	n/a	8.08M
Investing Cash Flow	2.83M	-121.09M	68.98M	34.44M	-114.97M	8.08M
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	n/a	10.98M	n/a	n/a	149K	n/a
Financial Cash Flow	-21K	130.73M	841K	n/a	177.23M	4.93M
Net Cash Flow	-51.54M	-5.88M	49.53M	-3.34M	26.44M	-736K
Free Cash Flow	-54.54M	-15.56M	-20.6M	-37.37M	-36.07M	-14.1M
Adj. Free Cash Flow	-62.6M	-21.12M	-33.41M	-44.36M	-39.81M	-14.81M
Maintenance CapEx	-97K	n/a	n/a	n/a	n/a	n/a
Growth CapEx	-89K	n/a	n/a	n/a	n/a	n/a
Owner Earnings	-54.45M	-15.56M	-20.6M	-37.37M	-36.07M	-14.1M